[Post-exposure prophylaxis against Ebola virus: arguments for expanding the role of monoclonal antibodies in a context of limited access].
- DOI
- 10.48327/mtsi.v6i1.2026.835
- Published
- 2026 Mar 31
- Container
- Medecine tropicale et sante internationale
- Publisher
- MTSI
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.48327/mtsi.v6i1.2026.835,
title = {[Post-exposure prophylaxis against Ebola virus: arguments for expanding the role of monoclonal antibodies in a context of limited access].},
author = {Potet J and Adjaho I and Dierberg K and Sprecher A and Coulborn RM},
year = {2026},
journal = {Medecine tropicale et sante internationale},
doi = {10.48327/mtsi.v6i1.2026.835},
url = {https://doi.org/10.48327/mtsi.v6i1.2026.835}
}RIS
TY - JOUR TI - [Post-exposure prophylaxis against Ebola virus: arguments for expanding the role of monoclonal antibodies in a context of limited access]. AU - Potet J AU - Adjaho I AU - Dierberg K AU - Sprecher A AU - Coulborn RM PY - 2026 JO - Medecine tropicale et sante internationale DO - 10.48327/mtsi.v6i1.2026.835 UR - https://doi.org/10.48327/mtsi.v6i1.2026.835 ER -
APA
J, P., I, A., K, D., A, S., & RM, C. (2026). [Post-exposure prophylaxis against Ebola virus: arguments for expanding the role of monoclonal antibodies in a context of limited access].. Medecine tropicale et sante internationale. https://doi.org/10.48327/mtsi.v6i1.2026.835
Source records
- pubmed · retrieved 2026-09-26T17:14:10.128Z
- europe-pmc · retrieved 2026-09-26T17:14:10.145Z
- datacite · retrieved 2026-09-26T17:14:10.127Z